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ABSTRACT We constructed chimeras of the rat [32 and [34 neuronal nicotinic 
subunits to locate the regions that contribute to differences between the acetylcho- 
line (ACh) dose-response r lationships of the cx3132 and cx3134 receptors. Expressed 
in Xenopus oocytes, the r receptor displays an ECs0 for ACh ~ 20-fold less than 
the ECs0 of the ct3134 receptor. The apparent Hill slope (napp) of ~t3132 is near one 
whereas the ct3134 receptor displays an nap  near two. Substitutions within the first 
120 residues convert the EC50 for ACh from one wild-type value to the other. 
Exchanging just [32:104-120 for the corresponding region of [34 shifts the ECs0 of 
ACh dose-response r lationship in the expected irection but does not completely 
convert he ECs0 of the dose-response r lationship from one wild-type value to the 
other. However, substitutions in the [32:104-120 region do account for the relative 
sensitivity of the ~t3132 receptor to cytisine, tetramethylammonium, and ACh. The 
expression of [34-like (strong) cooperativity requires an extensive region of [34 
([34:1-301). Relatively short [32 substitutions ([32:104-120) can reduce cooperativity 
to [32-like values. The results suggest hat amino acids within the first 120 residues 
of [32 and the corresponding region of [34 contribute to an agonist binding site that 
bridges the et and [3 subunits in neuronal nicotinic receptors. 
INTRODUCTION 
Both the ot and non-~t subunits of the nicotinic acetylcholine receptor (nAChR) play a 
role in the activation of  the receptor by agonist (reviewed in Deneris, Connolly, 
Rogers, and Duvoisin, 1991; Karlin, 1993; Papke, 1993). Although many studies 
show that agonist binds to the tx subunit (reviewed in Karlin, 1993), present opinion 
is divided about the possibility of an agonist binding site at the tx/non-et subunit 
interface (Cockcroft, Osguthorpe, Barnard, and Lunt, 1990; Karlin, 1993; Unwin, 
1993). The evidence for an ~x-only binding site is that 9-~ images of  Torpedo nAChRs 
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746 THE JOURNAL OF GENERAL PHYS IOLOGY 9 VOLUME 105 9 1995 
reveal a unique cleft within the a subunit hat could act as an agonist binding pocket 
(Unwin, 1993). However, there is no evidence that agonists actually bind within this 
cleft and contact only ec-subunit residues. On the other hand, previous experiments 
show that (a) the muscle-type a subunit (al) binds nicotinic agonists with appreciable 
affinities only if it is complexed with a non-c~ subunit (Blount and Merlie, 1988) and 
(b) the competitive antagonist d-tubocurarine (d-l'C) photolabels residues on the -y 
and G subunits of Torpedo nAChRs (Pedersen and Cohen, 1990; Chiara and Cohen, 
1992), which is strong evidence for a direct participation of the non-et subunits in an 
agonist binding site. However, dTC is a larger molecule than ACh and may not 
contact exactly the same residues that ACh does. Large quantities of purified 
neuronal nAChRs are not available for direct biochemical and structural analyses of 
potential agonist binding sites. We have exploited the fact that a3132 and et3134 
neuronal nAChRs expressed in Xenopus oocytes display different relative sensitivities 
to the ganglionic agonists, cytisine (CYT), tetramethylammonium (TMA), acetylcho- 
line (ACh) and nicotine (Leutje and Patrick, 1991; Figl, Cohen, Quick, Davidson, and 
Lester, 1992), and different dose-response r lationships for ACh (Couturier, Erkman, 
Valera, Rungger, Bertrand, Boulter, Ballivet, and Bertand, 1990; Cachelin andJaggi, 
1991; Leutje, Piattoni, and Patrick, 1993; Wong, Mennerick, Clifford, Zorumski, and 
Isenberg, 1993), to locate the residues of 132 and 134 involved in agonist activation of 
the receptor. 
In an earlier study on coexpressed c~3 and 13 subunits, we used 134"132 chimeras. 
Extending the 134 NHe-terminal region of a chimera from residues 134:1-105 to 
134:1-122 (Fig. 1) changed the CYT/ACh and TMA/ACh response ratios from 
~3132-1ike (132-like) to c~3134-1ike (134-like) levels (Figl et al., 1992). These data 
suggested that 134:106-122, and the corresponding region of 132 (132:104-I20), 
contributes to an agonist binding site that bridges the a and non-a subunits. To test 
this hypothesis, we have extended the earlier studies with (a) more chimeric and 
mutated 13 subunits and (b) electrophysiological measurements of the agonist dose- 
response relationship, which we summarize by the half-maximal agonist concentra- 
tion (ECs0) and Hill coefficient (napp). The results show that the region of 134 that 
converts the ECs0 for ACh from a 132-like to a 134-like value overlaps the previously 
localized region that converts the CYT/ACh response ratios of 134 NH2-terminal 
chimeras from 132-like to 134-like values (Figl et al., 1992) and suggest that an 
important component of the agonist binding site lies within the first 120 residues of 
132 and the corresponding region of 134. Some of our results have been reported 
previously in abstract form (Figl, Cohen, Gollub, Davidson, and Lester, 1993). 
METHODS 
Construction of the ~ Chimeras and Mutants 
We created chimeras between the 132 and 134 subunits by taking advantage ofshared restriction 
sites in the two subunits and using the polymerase chain reaction (PCR) to generate 
overlapping cDNA fragments (Higuchi, 1990) from the two subunits. Fig. 1 shows an alignment 
of 132 and 134 amino-acid sequences. Most of the chimeras contained the NH2-terminal region 
from one 13 subtype joined to the succeeding COOH-terminal residues from the other 13 
subtype (NH~-terminal chimeras). We refer to the NHe-terminal chimeras in the text by 
 o
n
 D
ecem
ber 27, 2006 
w
w
w
.jgp.org
D
ow
nloaded from
 
COHEN ET AL. Agonist Activation of Neuronal nAChRs 747 
FIGURE 1. The aligned amino acid sequences of the rat [32 and [34 neuronal nAChR subunits. 
The boxes outline identical residues and the shading denotes homologous residues. Residue 1 
begins after the termination of the leader sequences (not shown). The arrows above the [34 
sequence point to the transitions in the [34 NH2-terminal chimeras between the [34 and IB2 
sequence. The arrows beneath the [32 sequence point to the transitions in the [32 NH2-terminal 
chimeras between the [32 and [34 sequence. The numbers above (below) the arrows are the last 
residues in the B4 ([32) NHz-terminal regions of the chimeras, The lines beneath the [32 
sequence denote the transmembrane r gions M1-M4. 
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transition points between the two types of 13 subunits. For example, 132(229)'134 is a chimera 
containing the first 229 residues of 132 joined to residues 232-475 of 134 (see Fig. 1). Chimeras 
containing internal substitutions are labeled by the end points of the substitution. For example, 
134"132(104-120)'134 is a chimera in which we substituted 132:104-120 for residues 106-122 of 
the 134 subunit (these labels have been shortened to 132(104-120) and 134(106-122) in Figs. 7 
and 8). 
To create the 132(229)'134 and 134(231)'132 chimeras, we excised the cDNA fragments for 
residues 132:1-229 and 134:1-231 from the wild-type subunits with EcoRI and BbsI, subcloned 
the excised fragments into the complementary restricted plasmid from the opposite 13 subunit, 
and sequenced the region around the 134/132 transition to check the final product. The 
remaining chimeras were constructed in three steps: (a) we synthesized two or more separate 
PCR fragments; (b) we annealed and amplified the PCR fragments; and (c) we inserted the 
annealed fragment into the appropriate r striction sites in the wild-type plasmid. We normally 
introduced a silent mutation into the chimera during the initial PCR reaction to allow us to 
check the final product by restriction analysis. In addition, all the chimeras were verified by 
DNA sequencing. We made point mutations using the Altered Sites Kit (Promega Corp., 
Madison, WI) and verified the mutations by restriction analysis and DNA sequencing. Point 
mutations are denoted in the text by subscripts that contain the single letter code for the 
original residue, followed by its position in the sequence, and the residue to which it was 
mutated. We synthesized mRNA in vitro using the MEGAscript Kit (Ambion, Austin, TX) or a 
previously published method (Guastella, Nelson, Nelson, Czyzyk, Keynan, Midel, Davidson, 
Lester, and Kanner, 1990) and checked the size of the synthesized mRNA by agarose gel 
electrophoresis. 
Oocyte Expression 
Stage V-VI Xenopus oocytes were isolated as described previously (Quick and Lester, 1994) and 
injected with mRNA in a stoichiometric ratio for 0L:13 of 2:3. The amount of mRNA injected 
(< 25 ng/subunit) was adjusted to maintain a maximum response (/max) of < 10 ~ at -50 inV. 
Before recording, the oocytes were incubated for 2-7 d at 18~ in a modified Barth's olution 
supplemented with 50 ~g/ml gentamicin, 2.5 mM pyruvate, and 5% horse serum (Quick and 
Lester, 1994). 
Electrophysiological Recordings 
The oocytes were voltage clamped at -50 mV with two, 3 M KCl-filled microelectrodes made 
from thick-walled borosilicate glass (model BF150-86-10, Sutter Instrument Co., Novato, CA) 
and an AxoClamp 2A voltage clamp (Axon Instruments, Foster City, CA). During the 
experiments, we perfused the recording chamber (~ 1.5 ml vol) with 98 mM NaCl, 1 mM 
MgC12, and 5 mM HEPES (pH 7.4) at room temperature (20-24~ at 10-20 mi/min. We 
omitted Ca ~+ from the recording solution because the entry of Ca 2§ through neuronal nAChRs 
can activate the endogenous Ca2+-activated C1- current of the oocyte (Vernino, Amador, 
Leutje, Patrick, and Dani, 1992). 
We applied agonists to the oocytes by pinching-off the outflow of a U tube (Bormann, 1992) 
with a solenoid-activated pinch valve (Cole-Palmer, Niles, IL) under computer control. The 
time constant of the approach to a steady state response ('to,) was 0.4-0.5 s at slowly 
desensitizing agonist doses. To check the effective [agonist] reaching the oocyte from the U 
tube, we applied a slowly desensitizing dose of ACh (1 IxM) to an oocyte expressing (x3132 using 
the bath and U tube perfusion systems. Bath and U tube application of 1 v.M ACh produced 
the same steady state response. Endogenous muscarinic responses were rare and easily 
identified by their oscillatory nature and delayed onset after agonist application from the U 
tube. We did not use oocytes exhibiting muscarinic responses. 
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COHEN ET AL. Agonist Activation of Neuronal nAChRs 749 
Collection and Analysis of the Dose-Response Data 
We recorded the responses to 6-11 different agonist doses to measure the dose-response 
relationships for individual oocytes. The agonist was applied in 6-s pulses separated by a 
2-3-rain rinse with control saline. The responses were filtered at 20 Hz and digitized at a 
sampling frequency of 50 Hz using an MS-DOS computer equipped with pCLAMP V5.5 
software (Axon Instruments). 
We fit the dose-response data for individual oocytes to the Hill equation, 
/max 
/peak = {ECsoInapp '
I+~[A I ]  
where Ip~k was the peak response at agonist concentration [A], using weighted nonlinear 
least-squares regression. To reduce the interdependence of the parameters/max, ECs0, and napp, 
we allowed only the /max and the ECs0 to vary when fitting to the Hill equation. The napp was 
fixed at the mean slope of the Hill plots for the receptor subtype being fit. The napp was 
determined (a) from the Hill plot by linear regression of log[lp~,/(I,~- lp~ak )] against 
Iog[agonist] where/max was the maximum observed response and (b) from the log-log plot by 
regression at the foot of the dose-response r lationship. The correlation between these two 
measurements of the napp was 0.89 for the 26 receptor types discussed in the text. Regression of 
the log-log slope against he corresponding Hill slope predicted a log-log slope of 1.1 for a 
Hill slope of 1.0 and a log-log slope of 1.9 for a Hill slope of 2.0. We preferred the estimates of 
the napp from the Hill plot because (a) the slope of the Hill plot was based on more points per 
oocyte than the initial log-log slope measurements, (b) log-log slope measurements tend to 
underestimate he true napp, (c) the Hill plot included more data points with a higher 
signal/noise ratio than the initial log-log plot, and (d) the n~pp'S from the Hill plot generally fit 
the dose-response relationship better than the napp'S from the log-log plots. The napp'S reported in 
the text are from Hill slopes rather than from log-log slopes unless stated otherwise. We 
weighted the residuals by 1/~/Ipeak for the fit to the Hill equation because the variance of Ipe~, at 
the high end of the dose-response r lationship was larger than the variance of lp,a at the low 
end. Repeated measurements ona single oocyte showed that long-term desensitization reduced 
the/ma~ but did not affect the ECs0 or n~pp. 
To compare measurements of the ECs0 with widely different variances, we transformed the 
ECs0's to log values. Unless otherwise stated, the measurement errors reported in the text are 
standard eviations (SDs) and the SDs for the ECs0's given in the text are for untransformed 
data. To construct normalized ose-response relationships for the receptors, we normalized the 
individual dose-response r lationships to the fitted lm.~'S and pooled the resulting data. We 
then refit the Hill equation allowing only the ECs0 to vary. The error reported for the 
normalized ECs0 measurements is the standard error of estimate (SEE). 
Correction of the Peak Response for Desensitization 
Rapid desensitization reduces the peak response because some receptors desensitize while the 
[agonist] is still rising around the oocyte. We used the following three-state scheme (Scheme I) 
to calculate depression of the peak response by rapid desensitization, 
kl k2 
C---~O--->D, 
SCHEMEI 
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750 THE JOURNAL OF GENERAL PHYSIOLOGY 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9 1995 
where C, O, and D are the closed, open, and desensitized states of the receptor, k~ is the rate 
constant for the [ACh] to reach a steady state around the oocyte, and k 2 represents the rate 
constant for desensitization. We obtained kj directly from the rate constant of the rising phase 
of the response with 1 ~M ACh and k 2 directly from the rate constant of the decay of the 
response within the agonist pulse (in the Results section, 1/kl and 1/k2 are termed Ton and 
~de~n). The relationship between the peak amplitude of the observed response (/peak) and the 
peak amplitude of the calculated response (Icalc) is, 
peak 
/calc = kl [[kl]kl/(k2_kl , {kl]k2/(k2_k,) ] (1)  
k2 - kl [~k2] - ~2] J 
At high [ACh]'s, the decay of the response consisted of two exponential components. These 
components were corrected separately using Eq. 1 and then summed to obtain the final 
calculated peak response. 
RESULTS 
The [3 Subunit Affects the Agonist Dose-Response Relationship 
Consistent with previous data (Couturier et al., 1990; Leutje et al., 1993; Wong et al., 
1993), we found that the 13 subunit profoundly affects the sensitivity of  neuronal 
nAChRs to ACh. Expressing a3 with [32, instead of  with [34, shifted the ACh 
dose-response r lat ionship at -50  mV considerably to the left and reduced its slope 
(Fig. 2). The traces in Fig. 2, A and B, are typical ACh responses of  ~t3132 (Fig. 2 A ) 
and ~x3134 (Fig. 2 B) from oocytes with similar maximum responses. We fit the ACh 
FIGURE 2. (opposite) Expressing et3 with [32, rather than with [34, reduces the EC~0 and 
apparent Hill coefficient (napp) of the ACh dose-response relationship. (A) Responses of a3132 to 
1-300 o~M ACh. The numbers are the [ACh] in o,M. The square pulse above the traces is the 
duration of the application of ACh from the U tube. (B) Responses of ~t3[$4 to 20-1,000 ~M 
ACh. (C) Dose-response plots for ~t3152 and oL3[M. The symbols denote different oocytes 
expressing ~t3[32 (filled circles, open circles, filled inverted triangles, open reverted triangles, filled 
squares) or ~t3134 (open squares, filled upright triangles, open upright triangles). The lines are fits to 
the Hill equation (see Methods). The EC50's and the /max'S are 17 ~M and 1,863 nA (filled 
circles), 13 ~M and 1,757 nA (open circles), 15 ~M and 2,056 nA (filled inverted triangles), 9 ~M 
and 1,461 nA (hollow inverted triangles), 13 ~M and 1,498 nA (filled squares), 216 o,M and 1,944 
nA (open squares), 232 o.M and 2,061 nA (filled upright riangle), and 209 ~M and 2,100 nA (open 
upright triangle). Voltage = -50  mV. (D) Hill plots for the peak ACh responses (/peak) of ct3[32 
and ~t3[M. /max is the maximum observed /peak. The symbols denote different oocytes; ot3132 
(filled circles, hollow circles), tx3134 (filled inverted triangles, hollow inverted triangles, filled squares). 
Overlap obscures ome of the data. The napp'S are 0.9 (filled circles), 1.0 (open circles), 2.2 (filled 
inverted triangles), 2.3 (inverted triangles), and 2.2 (filled squares). (E) Log-log plots of the foot of 
the ACh dose-response r lationship show that the slope of the ct3[34 log dose-log response 
relationship is ~ twice that of ~t3[32. The symbols represent data from six oocytes (each oocyte is 
represented by a different symbol). The lines are regression lines fit to the log-log data. The 
slopes for ct3134 are 2.0 (filled circles), 2.0 (open circles), and 1.8 (filled inverted triangles); the 
slopes for ot3132 are !. 1 (hollow inverted triangles), 1.0 (filled squares), and 1.0 (hollow squares). 
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dose-response r lationships for et3l~2 and a3134 to the Hill equation (Fig. 2 C) using 
the napp'S for a3132 and a3134 determined from Hill plots of the ACh responses (Fig. 
2 D). Similar to previous results (Couturier et al., 1990; Leutje et al., 1993; Wong et 
al., 1993), the ECs0 for ACh was 11 - 4 ~M (mean _+ SD, n = 29 oocytes) for the rat 
a3132 receptor and 219 -+ 12 txM (n = 3) for the rat et3134 receptor. The nap  for a3[~2 
was 1. I _ 0.2 (n = 29) and the napp for a3134 was 2.2 -+ 0. I (n = 3). Fig. 2 D shows 
Hill plots for the two receptors. Measurements of the napp from the initial slope of a 
log-log plot of the dose-response r lationship (where desensitization and agonist 
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9 1995 
self-block are minimal) gave similar, but slightly smaller, napp'S for cx3132 (0.9 + 0.1, 
n = 11) and ~3134 (1.9 + 0.1, n = 3). Fig. 2 E shows examples of the initial portions 
of the log(dose)-log(response) r lationships for the two wild-type receptors. The 
agreement of these measurements shows that the difference between the napp'S of 
cx3132 and ~3134 was not due to desensitization or open-channel b ock by the agonist. 
Injecting equal amounts of mRNA generally gave much larger maximal ACh 
responses for ~x3134 than for cx3132 (~ 10-fold) but we did not study these differences 
further. 
The dose-response r lationships of ~x3[32 and r for TMA displayed ifferences 
comparable to, but less pronounced than, those for ACh (Fig. 3). Fig. 3, A and B, 
shows sample responses of cx3132 (Fig. 3A) and ~x3134 (Fig. 3B) to TMA. Rapid 
desensitization is less pronounced for both wild-type receptors with TMA as the 
agonist. The ECs0 of cx3[32 for TMA (76 -- 11 o~M, n = 7) was fivefold smaller than 
that of cx3134 (424 --- 94 p,M, n = 6) and the napp of r for TMA (1.4 -+ 0.1, n = 7) 
determined from Hill plots of the dose-response data was significantly smaller than 
the napp of r (2.0 -- 0.2, n = 6). As with ACh, the [32 subunit shifts the TMA 
dose-response considerably to the left (Fig. 3 C). Thus, the [3 subunit affects the 
activation of neuronal nAChRs by an agonist that contains only the quaternary 
ammonium portion of the ACh molecule; and the effects of the [3 subunit on the 
agonist dose-response r lationship ersist even with an agonist hat desensitizes the 
receptor more slowly than ACh. 
Rapid Desensitization Fails to Account for Differences in the ECso'S of o_3[32 
and a3134 
The response of cx3132 to ACh (Fig. 2 A) desensitized more quickly than the response 
of ~3~4 to ACh (Fig. 2 B). The time constant %n for activation of the ~3132 response 
to 1 p~M ACh to reach a steady state was 0.4-0.5 s. The time constant "rdesen for the 
desensitization of the a3~2 response decreased from 5-7 s at 3 ~M ACh to 0.6-0.8 s 
at 300 ~M ACh. Desensitization of the ~3132 response to 300 p-M ACh was biphasic 
with an additional slow time constant of 5-6 s. The ~3~4 receptor displayed little 
desensitization during the 6-s agonist pulse. The ~desen for ~3~4 was 5-6 s at 1-2 mM 
ACh and was too slow to measure at 20-500 ~M ACh. 
We corrected the peak ACh response of the wild-type receptors for apparent 
desensitization (see Methods) and fit the corrected data to the Hill equation to 
determine how much of the difference in the ECs0's could be due to a difference in 
the rate of desensitization. Correcting the peak response of ~3132 for apparent 
desensitization left napp unchanged but increased the ECs0 of ~x3[~2 for ACh twofold. 
Desensitization of ~3~4 did not significantly affect the ACh dose-response r lation- 
ship. Thus, allowing for the potential effects of desensitization, the ECs0 of ~3134 for 
ACh was still 10-fold larger than the ECs0 of ~3132. The differences in desensitization 
accounted for such a small fraction of the differences between the EC50's of the 
wild-type receptors that we decided not to attempt o correct the amplitudes of the 
peak responses. We were unable to resolve desensitization occurring on a time scale 
faster than 1 s (Maconochie and Knight, 1992) using our drug application system (see 
 o
n
 D
ecem
ber 27, 2006 
w
w
w
.jgp.org
D
ow
nloaded from
 
COHEN ET AL. Agonist Activation of Neuronal nAChRs 753 
Methods). Such desensitization would produce an apparent decrease in the ECs0 of 
the dose-response relationship in our experiments. 
NH2-Terminal Substitutions of105 or More [34 Residues Increase the ECso for ACh 
Substitutions of  94 or fewer 134 residues had only small effects on the ECs0 for ACh 
(Fig. 4 A); the ECs0's of the et3134(16)'132, et3134(81)-132, and ot3134(94)-132 chimeras for 
A o~3/22 B 
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FIGURE 3. Expressing a3 with 134, rather than with 132, increases the ECs0 and the nap p of the 
TMA dose-response r lationship. (A) Responses of et3132 to 5-200 I~M TMA. The responses are 
labeled with the [TMA] in IxM. The square pulse above the traces shows the timing of the TMA 
application. (B) Responses of a3134 to 50-2,000 o~M TMA. (C) Expression with 134 shifts the 
TMA dose-response relationship to the right and increases its slope. The symbols are mean 
normalized responses +_ SD. The ECs0's of the TMA dose-response r lationships for ot3132 and 
ot3134 are 75 - 3 o,M (n = 7) and 416 _ 12 I~M (n = 6) ( -  standard error of estimate, -+SEE). 
ACh (13-18 I~M) were within a factor of two of the ECs0 of ct3132 for ACh. However, if 
the 134 NH2-terminal region of the chimeras was extended from 94 to 109 residues, 
the ECs0 for ACh increased dramatically to a 134-like value. Fig. 4 B presents data for 
the interesting region between residues 134:94 and 134:109 and shows the rightward 
shift of  the normalized ACh dose-response relationships as more [34 residues are 
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9 1995 
included. All the [34 NH2-terminal chimeras with 113 or more [34 NH2-terminal 
residues displayed [34-like EC50's for ACh (> 10-fold larger than that of  a3132). Thus, 
the [34/[32 residue substitutions necessary for [34-like ACh sensitivity in the [34"[32 
chimeras lie in the first 113 residues of  [34. 
A B 1000 
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FIGURE 4. (A) Substituting 105 or more [34 NH2-terminal residues for the corresponding 
region of [32 increases the ECs0 for ACh. The horizontal axis is the number of [34 NH2-terrninal 
residues in the chimera: zero for cx3132 and 475 for et3134. The symbols are the mean values for 
the two wild types and 14 [34"[32 chimeras (n = 2-29 oocytes). Overlap obscures ome of the 
data. The dashed lines are 1 -+ SD. The means and SDs for the ECs0'S were computed from log 
transformed ata. The vertical ine denotes the beginning of M1. (B) The addition of two 
residue substitutions in the [34:95-109 sequence (see Fig. 1) shifts the ACh dose-response 
relationship dramatically to the right. The symbols are the mean normalized responses -+ SD 
(see Methods) for ~3134(94)'[32, ~x3134(105)'[32, and ~3134(109)'[32. The lines are fits to the Hill 
equation (see Methods). The ECs0'S for ACh are 16 _ 1 I~M (n = 9), 60 - 4 ~M (n = 4), and 
338 -+ 23 [~M (n = 6), respectively (_+SEE). (C) Substituting >301 [34 NH~-terminal residues 
increases the nap  for ACh to > 2.0. 
There are only two [34/[32 residue substitutions in [34:95-109 (see Fig. 1). The 
addit ion of  these two substitutions increased the ECs0 of the [34 NH2-terminal 
chimeras from [32-like to [34-like levels. Therefore, we made the site-directed 
mutations [32M101T.I:106v tO change just  these residues in the [32 subunit. The ECs0 of 
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COHEN ET AL. Agonist Activation of Neuronal nAChRs 755 
the mutated receptor for ACh (19 +- 4 I,M, n = 5) was within a factor of two of the 
value for cx3152 (11 -+ 4 ~M). Thus, the increase in the EC~0 of or3154(109)-[32 over the 
ECs0 of cx3154(94)'[32 depended on residue substitutions within the first 94 residues of 
[54 in addition to the two substitutions [32:Met101~--~[54:Thr103 and [52:Phe106~--H34: 
Vail08. Previous experiments (Chiara et al., 1992; O'Leary, Filatov, and White, 1994) 
also suggest hat a tryptophan (,/:Trp55, ~:Trp57) in the first 60 residues of the 
non-or subunits contributes to the agonist binding sites of the Torpedo nAChR. 
We also made the mutation a3134(61)SZ8N'[32 to determine if the loss of a potential 
glycosylation site at [52:Asn26 was responsible for the slight decrease in the EC50 of 
0t3154(61).[52 below that of ct3152. The ECs0 (6 -+ 3 tzM, n = 4) and napp (0.8 • 0.1, 
n = 4) of Ct3154(61)SZSN'[52 for ACh were not significantly different from the ECs0 
(5 -+ 1 IrM, n = 6) and the nap p (1.0 4- 0.1, n = 6) of or3154(61)'[52. Thus, the removal 
of a potential glycosylation site at [52:Asn26 was not responsible for the effect of 
ct3134(61)'[32 on the EC50 for ACh. 
Increasing the nat~ to [34-like Values Requires an Extensive Region of [34 
The nap p of the [54"[52 chimeras howed a more gradual dependence on the [54/[32 
transition point than the EC50. The napp'S of  these chimeras fell into three categories, 
[52-like (napp = 1.0-1.2), intermediate (napp = 1.6), and [54-like (napp = 2.0-2.2). The 
chimeras containing 109 or less [54 NHz-terminal residues exhibited [52-like napp'S; 
the chimeras containing 109-231 [34 NHz-terminal residues exhibited intermediate 
napp'S except for cx3134(122)'[52 (napp = 1.2 + 0.2, n = 2); and the chimeras contain- 
ing 301 or more [54 NHz-terminal residues exhibited [54-like napp'S. The [52MI01T, F106V 
mutation did not affect the napp for ACh. 
We are not surprised by the differences between the regions of [54 that affect the 
ECs0 and those that affect the napp. Areas of contact between the subunits outside the 
agonist binding site may affect the cooperativity of a multisubunit receptor (Kosh- 
land, Nemfithy, and Filmer, 1966). Nevertheless, the overlap between the [54 residues 
that increase the EC50's of the [34.[52 chimeras and the residues that increase the napp 
from [52-like to intermediate values suggests that [54:106-122 and [52:104--120 may 
be areas where the ct and [5 subunits contact each other. The results for the [54 
NH2-terminal chimeras also suggest hat these subunits contact each other some- 
where between the end of the first putative transmembrane domain M1 and the 
initial portion of the M3-M4 intracellular loop. However, our data do not allow us to 
exclude the alternative hypothesis that these residue substitutions produce a confor- 
mational change in the receptor that affects cooperativity indirectly. 
Substituting fl2:1-120 for the Corresponding Region of [34 Reduces the ECso 
to a [32-like Value 
We constructed a number of [52-[54 chimeras to determine the region of the [52 
subunit required to reduce the ECs0 of the chimeras to [32-like values (Fig. 5 A). 
Similar to results for the [54"[52 chimeras, substituting the first 120 residues of [52 for 
the corresponding region of [54 reduced the ECs0 for ACh to 16 4- 8 IxM (n = 3) 
which resembles the ECs0 of ct3152 (11 4- 4 izM). Fig. 5 B shows the effect of this 
substitution on the ACh dose-response r lationship. Substituting the first 92 residues 
of [52 also reduced the ECs0 for ACh (Fig. 5 A). Thus, residue substitutions in the first 
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9 1995 
92 amino acids of 62 do affect the sensitivity of  the receptor to agonist but this effect 
is masked in the 64 NH2-terminal chimeras. 
There is an anomalous member  of  the ~2"[M series; the ECs0 of ct362(229)'[M for 
ACh was close to that of  ct364 (Fig. 5 A ). This anomalous ECs0 does not seem to be 
A 
g 
P,, 
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10 
1 i 
I I I 
0 I O0 200 
C 
/ 
c~3#2 
I I I 
300 400 500 
2.5 
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"• 0.5 
0.0 
0.1 
i I i i 
. . . . . . . .  i ........ t , , l , , , , , I  , , ,Hml  
1 10 100 1000 
[ACh] (/~M) 
2.0  
c ~ 1.5 
1.0 
0.5 
0 100 200 .300 400 500 
# of N-terminal  /92 Residues 
F IGURE 5 .  (A )  132 NH2-terminal substitutions have a more complex effect on the ECs0 for ACh 
than 134 NH~-terminal substitutions. The symbols are mean values for the two wild types and 
five 132 NHe-terminal chimeras (n = 3-29). The dashed lines are -+ SD. The vertical line 
denotes the beginning of M 1. (B) Substituting [32:1-120 for the corresponding region of 64 
reduces the ECs0 to a [32-like value. The symbols are the normalized responses -+ SD. The lines 
are fits to the Hill equation. The ECs0's for ~t3132(120)'~4 and (~3~4 are 15 _ 3 p~M (n = 3) and 
215 _+ 8 ~M (n = 3) ( -  SEE). (C) Substituting 93 or more 132 NH2-terminal residues for the 
corresponding regions of 134 reduces the nap p for ACh to ~2-1ike values. 
due to a disruption of the agonist binding site. Previous data show that this chimera 
displays a 62-like affinity for the irreversible competit ive inhibitor, neuronal bunga- 
rotoxin (Papke, Duvoisin, and Heinemann, 1993), and we found that (~362(229)'~4 
exhibits a clear [32-like insensitivity to CYT relative to ACh (Fig. 6). 
Thus, the results for the 64 and 62 NH2-terminal chimeras show that 132/134 
substitutions in the first 120 residues of 132 and the first 113 residues of  {34 are 
sufficient to convert the ECs0 for ACh from one wild-type value to another. 
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Short [32 NH2-Terminal Substitutions Disrupt he Cooperativity ofthe Receptor 
[$2 NH2-terminal sequences of 92 or more residues reduced the napp for ACh to a 
value near that of ~3[$2 for ACh (1.1 - 0.2) (Fig. 5 C). Moreover, a single measure- 
ment of the napp (1.1) for 0~3[$2(59)'[$4 from the initial portion of the log-log dose 
response relationship suggests that even substituting the first 59 residues of [$2 for 
the corresponding region of [$4 may suffice to reduce the napp of the chimera to a 
[$2-1ike value. Thus, as for the [$4 NH2-terminal chimeras, changes in the ECs0'S of 
the [$2 NH2-terminal chimeras were not synchronous with changes in the napp. If the 
napp is determined by areas of contact between the subunits, then these results 
suggest that an extensive region of subunit/subunit contacts, particularly at the 
NH2-terminals of the ~3 and [$4 subunits, are required for the receptor to display the 
strong cooperativity observed for the 0t3[$4 receptor. The small napp of the 
~3[$2(120)-[$4 raises the possibility that there may also be heterogeneity in the 
assembly of this receptor. The ~3[$2(92)'[$4 and ~3[$2(229)-[$4 chimeras also display 
Hill coefficients that are slightly < 1. 
A ~3#2(229)-#4 B ~5#2 
Agonlst Agon~st 
l f~'30 <#'M AC h-- L / /~- - - - -  
C ~,3,84(231)'#2 D o~,3/24 
FIGURE 6. The ~3[$2(229)'[34 chi- 
mera displays a [32-like insensitivity to 
30 ~M CYT relative to ACh. (A-D) 
Responses to 30 ~M CYT and 30 ~M 
ACh at -50 inV. The square pulses 
above the traces denotes the release 
of agonist from the U tube. 
Exchanging Just [32:104-120 and [34:106-122 Shifts the ECso 
in the Expected Direction 
Mutations show that the two [$4/[$2 substitutions [$2:Metl01<--~[$4:Thrl03 and [$2: 
Phel06<--~[$4:Vall08 are not sufficient o change the ECs0 of the ACh dose-response 
relationship. We therefore constructed the reciprocal chimeras a3[$4"[$2(104-120)'[$4 
and a3[$2-[$4(106-122)-[$2 to test whether more extensive substitutions in this area 
could affect the ECs0 for ACh. Exchanging [$2:104-120 and [$4:106-122 shifted the 
ECs0 for ACh towards the opposing wild-type value (Fig. 7,A and B). Substituting 
[$2:104-120 for the corresponding region of [$4 reduced the ECs0 for ACh to 90 - 20 
~M (n = 4), a value less than half that of o~3fl4 (219 - 12 ~M). The reciprocal 
substitution ([$4:106-122 for the corresponding region of [$2) increased the EC~0 
about threefold over the ECs0 for a3[$2, to 28 -+ 6 ~M (n = 8). Consistent with the 
results for the [$2 and [$4 NH2-terminal chimeras, substituting [$2:104-120 reduced 
the cooperativity of the chimera to 1.3 + 0.1 (n = 4) while the reciprocal substitution 
did not significantly increase the napp for ACh (1.3 - 0.2, n = 8). Thus, eight residue 
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9 1995 
substitutions in [32:104-120 and 134:106-122 (see Fig. 1) had an effect on the ECs0 
and napp for ACh that was independent of substitutions elsewhere in the [3 subunits. 
Substituting [32:104-120 for [34:106-122 Also Affects Agonist Selectivity 
Previous data (Figl et al., 1992) show that extending the [34 region of a 134 
NH2-terminal chimera from 134:1-105 to [34:1-122 increases the 30 ixM CYT/30 IxM 
ACh (CYT/ACh) and 100 t~M TMA/30 tzM ACh (TMA/ACh) response ratios from 
[32-like to 134-like levels. We tested the effects of exchanging 132:104-120 and 
134:106-122 to determine whether these regions accounted for the effects of the 134 
NH2-terminal chimeras on agonist selectivity. 
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FIGURE 7. Exchanging 132:104-120 and 
134:106-122 shifts the EC~0 of the ACh dose- 
response relationship in the appropriate di- 
rection. (A) Substituting 132:104-120 for 
134:106-122 shifts the ACh dose-response 
relationship to the right of the ~3134 dose- 
response relationship. (B) Substituting [34: 
106-122 for 132:104-120 shifts the dose- 
response relationship to the left of the ~3132 
dose-response relationship. 
Substituting [32-104-120 for [34:106-122 reduced the CYT/ACh and TMA/ACh 
response ratios to 132-like values (Fig. 8, A and B), but the reciprocal substitution 
[34:106-122 for 62:104-120 produced only a small increase in the CYT/ACh or 
TMA/ACh response ratios toward 134-like values. Thus, similar to the effects of [32 
substitutions on cooperativity, short internal substitutions reduce, but do not restore, 
the relative sensitivity of the a3134 receptor to ganglionic agonists uch as CYT and 
TMA. The structural basis for this correspondence between the effects of internal 
substitutions on agonist selectivity and cooperativity is unclear. Nonetheless, the 
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effects of  exchanging 134:106--122 and 132:104-120 on several measurements a soci- 
ated with agonist activation of  the receptor suggest hat these areas are places where 
the a and 13 subunits contact o form an agonist binding site. 
The Sole M2 Substitution Does Not Affect he ACh Dose-Response R lationship 
Dose-response r lationships for nAChRs are affected by mutations at several residues 
in the M2 transmembrane domain (reviewed in Karlin, 1993). There is a single 132/134 
substitution in the M2 region (132:Va1253~--~134:Phe255). We made the reciprocal 
A 
3 
B 
o 
3 
:& 
o 
2 ~L 
o 
o 
m m ,,, 
2.5 
2.0 
1~5 
1~0 
0.5 
0.0 
/ I I 
e3`84 fl4:106 ,82:104 c~3,82 
-122 -120 
FIGURE 8. Exchanging 132:104-120 and 
134:106-122 changes the ratio of the 30 o,M 
cytisine (CYT) and 30 I~M ACh responses 
and the ratio of the 100 I~M tetramethylam- 
monium (TMA) and 30 I~M ACh responses, 
(A) Substituting 132:104-120 for [$4:106-122 
reduces the CYT/ACh response ratio to a 
132-like value but substituting 134:106-122 
for [32:104-120 only marginally increases 
the CYT/ACh response ratio. The solid bars 
are means • SD. (B) Substituting 132:104- 
120 for 134:106-122 reduces the TMA/ACh 
response ratio to a 132-like value, Substitut- 
ing [34:106-122 for 132:104-120 increases 
the TMA/ACh response ratio to an interme- 
diate value. 
point mutations 134vz55v and 132v253r to test whether this substitution could shift the 
agonist dose-response r lationship. Neither mutation significantly affected the ECs0 
or napp. The napp of Ot3134F255V was 2.0 --+ 0.1 (n = 3); the napp of ot31327253F was 1.2 + 
0.1 (n = 3); the ECs0 of a3134E255v was 231 - 18 IxM (n = 3); and, the ECs0 of 
a3132v253~ was 9 - 1 IxM (n = 3). 
D ISCUSSION 
The data reported in this paper describe the steady state dose-response r lations of 
chimeric and mutated 139 and 134 subunits expressed with the a3 subunit in oocytes. 
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The data show that the first 120 residues of 132 and a comparable, but slightly 
shorter, region of 134 largely account for the different ECs0's of the wild-type 
dose-response r lationships. In the sharpest region of transition, chimeras that differ 
at only two residues have more than a 10-fold difference in the ECs0. However, when 
we examined the corresponding mutant  132M101T, F106V it retained the ECs0 of the 
wild-type 132 subunit. This important result shows that the two critical residues are 
interacting with other upstream residues during activation of the receptor. Longer 
substitutions in this region (132:104-120--,134:106-122) do affect (a) the ACh dose- 
response relationship and (b) the relative responses to several ganglionic agonists. 
The domains we have identified that affect the EC50 probably affect agonist binding 
and may contribute to an agonist binding site that bridges the ot and [3 subunits. 
Our experiments also bear on the regions responsible for the cooperativity of the 
receptor (napp). Regions of the 13 subunits responsible for differences in the napp 
overlap with, but are not identical to, those responsible for differences in the EC50. 
The 132:104-120 and 134:106-122 regions affect both measures. However, for the 134 
NHz-terminal chimeras, the transition from 132-like to 134-like cooperativity occurs 
more gradually than the transition from a 132-like to a 134-like ECs0 and requires an 
extensive NH2-terminal region of the 134 subunit. The high level of cooperativity of 
e~3134 is disrupted by short 132 substitutions. If receptor cooperativity is determined by 
areas of contact between the subunits (Koshland et al., 1966), then one of these 
contact regions appears to lie in 132:104-120 and 134:106-122. 
The differences we observed between the ACh dose-response r lationships of the 
~x3132 and ~x3134 receptors are similar to those reported previously by Couturier et al. 
(1990), Leutje et al. (1993), and Wong et al. (1993) but differ substantially from those 
reported by Cachelin et al. (1991 ). Cachelin et al. (1991) report a much smaller value 
for the EC50 of a3134 for ACh (30 ~M) and a much larger value for the ECs0 of ~3132 
for ACh (354 IxM). They report similar, but less diverse, napp'S for the two receptor 
subtypes (napp = 1.4 for c~3132; napp = 1.8 for a3134). The reason for this discrepancy 
is unclear but most of the previous measurements, including data from a mammalian 
expression system (Wong et al., 1993), are consistent with our data. 
The a3132(229)'134 chimera is anomalous because it displays a large, 134-like ECs0 
for ACh even though it includes regions of sequence that confer a 132-like ECs0 in 
another chimera tested. Nonetheless, the a3132(229)'134 chimera exhibits a 132-like 
CYT/ACh response ratio and a 132-like irreversible block by neuronal bungarotoxin 
(Papke et al., 1993). Based on its agonist selectivity and affinity for neuronal 
bungarotoxin, we suggest hat the large EC50 of this chimera rises from a change in 
the conformational states of the receptor that enhances the relative stability of the 
closed singly liganded receptor state (Koshland et al., 1966) rather than from a 
change in the agonist binding site. 
Channel Block by the Agonist Fails to Account for Differences in the Napp 
Measurements of the Hill coefficient at the foot of the dose-response r lationship 
show that the differences between the napp'S of the wild-type receptors are not due to 
channel block by the agonist because open-channel b ock is minimal in this region. 
However, open-channel b ock by the agonist could reduce the apparent ECs0 of the 
agonist dose-response r lationship. To assess the importance of this effect, we 
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calculated the dissociation constant Ki of agonist for an open-channel b ocking site 
that would yield a [32-like ECs0, assuming that (a) the agonist can open all the 
channels (a worst-case analysis), (b) (x3[B2 and (x3[B4 display a [34-like ECs0 for ACh 
(219 wM) in the absence of channel block, and (c) the nap p for cx3B2 is ~ 1. The 
fractional response of the receptor (Ipeak/Imax) under these conditions is 
/peak 1 
/max 219 wM [ACh] " 
I + - - + - -  
[ACh] Ki 
A Ki of 10 ~M would be required to bring the ECs0 to 24 ~M. Concentration- and 
voltage-jump experiments on neuronal nAChRs in bovine chromaffin cells suggest 
that the actual dissociation constant of ACh for the channel blocking site of neuronal 
nAChRs is closer to 700-1,400 ~M (Maconochie and Knight, 1992), or 70- to 
140-fold greater than the value required to bring the ECs0 for (x3132 to 24 p~M. 
Moreover, with a Ki of l0 ~M, the maximum response would occur at ~ 50 p,M ACh. 
Higher agonist concentrations would reduce the amplitude of the response, contrary 
to our data for (x3132 (Fig. 2A). Additionally, the sole substitution in M2, which is 
thought o contain the binding site for open-channel b ockers, has no effect. These 
results strongly suggest hat agonist self-block does not account for the differences in 
the ECs0'S that we observed. 
Residues in a Homologous Region of y and 6 Determine Curare Binding 
Three residue substitutions in the mouse ~/ and 5 subunits ('y:Ilell6(--~5:Valll8, 
~/:Tyrll7(--)~:Thrll9, ~:Ser161(--)8:Lys163) account for a 10-fold increase in the 
affinity of the (x[3~/ receptor over the cx[35 receptor for the competitive antagonist 
(+)-dimethyltubocurarine (Sine, 1993). Residues [32:Ilel 18 and [32:Phe119 in the rat 
neuronal nicotinic receptor are homologous to ~:Ile116 and ~:Tyrl 17 in the mouse 
receptor and they are in the [32:104-120 domain of the rat neuronal nicotinic 
receptor. More recent evidence (Xie, Chiara, and Cohen, 1994) shows that the 
competitive antagonist dTC also photolabels residues ~/:Tyrl 11 and ~/:Tyrl 17 in the 
Torpedo nAChR (homologous to [32:Ser113 and [32:Phel19 in the rat neuronal 
nicotinic receptor). Thus, in a domain homologous to 132:104-120 in the rat 
neuronal nicotinic receptor, we find (a) residues in the Torpedo ~ subunit that are 
photolabeled by dTC and (b) residues in the mouse "y and 5 subunits that affect 
competitive antagonist binding. Residues in [32:104-120 affect the napp, the EC~0, 
and agonist selectivity of neuronal nicotinic receptors. The proximity of residues in 
the muscle-type nicotinic receptors that affect binding and photolabeling by a 
competitive antagonist with those in the neuronal nicotinic receptor that affect the 
napp, the ECs0, and agonist selectivity supports the hypothesis that residues [32:104- 
120 contribute to an ~/[3 ligand binding site in neuronal nAChRs. 
Differences in Channel Gating Do Not Account for Differences in the 
Wild-Type ECso 
We consider a simple sequential model to suggest hat differences in agonist binding, 
rather than in the rates of conformational change, are primarily responsible for the 
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9 1995 
difference between the ECs0's of c~3~2 and 0t3134 for ACh. This kinetic scheme 
(Scheme II) can be summarized as follows, 
nA + R C ~O ~ I, 
SCHEME II 
where n is the Hill coefficient, A is the agonist, R is the free receptor, C is the closed 
agonist-bound receptor, O is the conducting state of the receptor, I is an agonist- 
bound inactivated state of the receptor, and KI-K3 are dissociation constants9 At 
equilibrium, the fraction of open receptors Po is, 
Po -- 
1 +~+K2+ [Aln 
The ECs0 is, 
ECs0 = K1 + Ks + K3K2 9 
According to the data of Papke and Heinemann (1991), Kz = 1.1 and 0.45, and K3 = 
10 and 20 for 0t3~2 and a3~4, respectively. The point here is not the absolute values 
of these numbers, but the fact that they differ by relatively small amounts for the two 
receptors9 A similar conclusion is reached from our own kinetic data on voltage-jump 
relaxations, to be published separately. These differences would change the ECs0 by 
less than twofold. Thus, differences in the cooperativity of binding and conforma- 
tional transitions of 0t3132 and ct3134 cannot account for the 20-fold difference we 
observed between the ECs0's of the wild-type receptors for ACh. This model suggests 
that the wild-type dissociation constants for agonist binding (K(s) differ by more than 
10-fold. 
Regardless of the particular kinetic model used, the differences between the mean 
open times of the 0t3132 and ct3~4 channels do not account for the differences in the 
ECs0'S ofct3~2 and 0t3~4 for ACh. The open channel lifetime is usually interpreted as 
the rate constant for leaving the open state of the channel9 The long open-channel 
lifetime of the primary a3134 channel is 75% greater than the long open channel 
lifetime of the primary a3~2 channel (Papke et al., 1991). All else being equal, this 
difference in open channel lifetime would be associated with a smaller ECs0 for 0t3~4 
than for c,3~2, contrary to the data9 
Conclusions 
Our study is the first attempt o determine the regions of sequence that account for 
the differences in the complete agonist dose-response r lationship roduced by two 
naturally occurring subunits of a channel. Past experiments on binding of antagonists 
or open-channel blockers have pinpointed just a few residues; however, channel 
activation in response to agonists is certainly a more complex phenomenon, 
involving binding, conformational changes, and interactions between the subunits. It 
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is therefore encouraging that clear trends emerge from the data. Our results 
emphasize the involvement of one region, 62:104-120, in the binding event and 
suggest that a broader region of sequence is involved in the subunit contacts and/or 
conformational changes that open the channel. 
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